(1)
Yang, J.; Zhao, M.; Zhou, X.; Yan, M.; Zhao, X.; Li, F. Cost-Effectiveness of Sorafenib, Lenvatinib, and FOLFOX4 for Advanced Hepatocellular Carcinoma in China. J Health Sci Med Res 2025, 43, e20251153.